Adams Brian — SEC insider filings
SEC reporting owner CIK 1636994. 47 insider filings on record with FilingPulse; latest filed 2026-09-04.
Transaction summary — filings shown
Covers all 47 filings on record, filed 2020-12-15 to 2026-09-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 43 legs across 38 filings — 157,126 shares, $2,760,922 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 3,025 shares @ $116.81 ($353,350) in Kymera Therapeutics, Inc., filed 2026-09-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Relay Therapeutics, Inc. (RLAY) | Chief Legal Officer | 44 | — | 40 legs · 150,755 sh · $2,016,625 | 22 |
| Kymera Therapeutics, Inc. (KYMR) | Chief Legal Officer | 3 | — | 3 legs · 6,371 sh · $744,297 | 4 |
Insider filings — Adams Brian
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-04 | 4 | Kymera Therapeutics, Inc. (KYMR) | Sale (S): 1,209 @ $115.55 · Sale (S): 3,025 @ $116.81 · Sale (S): 2,137 @ $117.57 | EDGAR |
| 2026-03-04 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 4,125 @ $0 · Grant/award (A): 8,250 (derivative) @ $0 | EDGAR |
| 2025-09-03 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 52,500 @ $0 · Grant/award (A): 105,000 (derivative) @ $0 | EDGAR |
| 2025-07-30 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,637 @ $3.74 · Sale (S): 18,276 @ $3.68 | EDGAR |
| 2025-04-30 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,644 @ $3.17 · Sale (S): 12,943 @ $3 | EDGAR |
| 2025-03-31 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 298 @ $2.84 | EDGAR |
| 2025-01-30 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 33,688 @ $4.63 · Grant/award (A): 139,141 @ $0 · Sale (S): 20,791 @ $4.42 | EDGAR |
| 2025-01-14 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 275,000 (derivative) @ $0 | EDGAR |
| 2024-12-31 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 299 @ $4.38 | EDGAR |
| 2024-10-30 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,632 @ $6.06 | EDGAR |
| 2024-10-01 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 295 @ $7.51 | EDGAR |
| 2024-07-31 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,638 @ $8.85 | EDGAR |
| 2024-07-01 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 295 @ $6.26 | EDGAR |
| 2024-04-29 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,623 @ $6.38 | EDGAR |
| 2024-03-29 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 348 @ $7.70 | EDGAR |
| 2024-01-31 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,929 @ $9.64 | EDGAR |
| 2024-01-18 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 200,000 @ $0 | EDGAR |
| 2023-12-29 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 294 @ $11.51 | EDGAR |
| 2023-11-01 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,632 @ $6.03 | EDGAR |
| 2023-09-29 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 294 @ $8.38 | EDGAR |
| 2023-07-31 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,628 @ $11.80 | EDGAR |
| 2023-06-28 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 294 @ $12.12 | EDGAR |
| 2023-06-01 | 4/A | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,936 @ $11.16 | EDGAR |
| 2023-05-01 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 863 @ $11.16 | EDGAR |
| 2023-03-28 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 347 @ $15.36 | EDGAR |
| 2023-01-31 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 864 @ $21.56 | EDGAR |
| 2023-01-19 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 85,425 @ $0 · Grant/award (A): 97,630 (derivative) @ $0 · Grant/award (A): 73,220 (derivative) @ $0 | EDGAR |
| 2023-01-13 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 9,994 @ $20 | EDGAR |
| 2022-12-28 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 295 @ $14.49 | EDGAR |
| 2022-11-01 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 728 @ $21.54 | EDGAR |
| 2022-09-29 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 294 @ $22.73 | EDGAR |
| 2022-07-29 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 734 @ $21.27 | EDGAR |
| 2022-06-28 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 300 @ $20.31 | EDGAR |
| 2022-05-02 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 708 @ $25.57 | EDGAR |
| 2022-03-31 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 333 @ $29.87 | EDGAR |
| 2022-01-31 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 39,270 @ $0 · Grant/award (A): 78,540 (derivative) @ $0 | EDGAR |
| 2022-01-07 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 658 @ $26.10 | EDGAR |
| 2021-12-27 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 295 @ $33.10 | EDGAR |
| 2021-11-16 | 4 | Relay Therapeutics, Inc. (RLAY) | Option exercise (M): 6,500 @ $4.12 · Sale (S): 6,500 @ $35.42 · Option exercise (M): 6,500 (derivative) @ $0 | EDGAR |
| 2021-09-27 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 293 @ $36.87 | EDGAR |
| 2021-09-13 | 4 | Relay Therapeutics, Inc. (RLAY) | Option exercise (M): 6,500 @ $4.12 · Sale (S): 6,500 @ $35.02 · Option exercise (M): 6,500 (derivative) @ $0 | EDGAR |
| 2021-06-30 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 293 @ $35.81 | EDGAR |
| 2021-06-09 | 4 | Relay Therapeutics, Inc. (RLAY) | Option exercise (M): 6,500 @ $4.12 · Sale (S): 6,500 @ $35 · Option exercise (M): 6,500 (derivative) @ $0 | EDGAR |
| 2021-04-28 | 4 | Relay Therapeutics, Inc. (RLAY) | Option exercise (M): 6,500 @ $4.12 · Sale (S): 6,500 @ $35 · Option exercise (M): 6,500 (derivative) @ $0 | EDGAR |
| 2021-03-26 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 15,870 @ $0 · Grant/award (A): 31,740 (derivative) @ $0 | EDGAR |
| 2021-01-29 | 4 | Relay Therapeutics, Inc. (RLAY) | Option exercise (M): 5,000 @ $4.12 · Sale (S): 5,000 @ $55.05 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2020-12-15 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 67,588 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-12-09 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1636994 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs